Tag: NASDAQ:OTIC

October 1, 2019

Applied Genetic Technologies Announces Strategic Collaboration with Otonomy

The companies will develop a gene therapy for patients with a sensorineural hearing loss, which is a form of congenital...
September 17, 2019

Otonomy Begins Phase 1/2 Trial of OT-413 for Hearing Loss

Otonomy (NASDAQ:OTIC) has announced it has begun a Phase 1/2 clinical trial of OTO-413 in patients with hearing loss. As...